Medicare Enrolled

Dr. Cheryl McDonald, M.D.

Infectious Disease · Fort Worth, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1125 COLLEGE AVE, Fort Worth, TX 76104
8178109810
Registered in NPPES since 2006
NPI: 1013982511 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McDonald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McDonald? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McDonald

Dr. Cheryl McDonald is an infectious disease specialist in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. McDonald performed 34,794 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. McDonald received a total of $193,915 from 36 pharmaceutical and/or device companies across 717 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McDonald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 4% volume in TX $193,915 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
34,794
Medicare services
Top 4% in TX for infectious disease
Not available
Unique patients (not deduplicated)
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
14,940 $36 $298
Dalbavancin injection, 5 mg
An injection of the antibiotic dalbavancin, administered in a 5 mg dose.
12,300 $12 $43
Panzyga immune globulin injection, 500 mg
An intravenous injection of Panzyga, a non-lyophilized liquid immune globulin product, administered in a 500 mg dose.
4,370 $52 $252
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
727 $62 $250
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
578 $16 $50
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
570 $50 $158
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
430 $93 $227
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
288 $93 $225
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
134 $101 $297
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
122 $12 $55
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
115 $61 $148
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
94 $137 $434
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
42 $127 $349
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
32 $18 $54
Blood draw from central venous catheter
A procedure to collect a blood sample directly from a central venous tube or catheter.
28 $23 $55
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
24 $39 $89
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
46.3% high complexity
48.3% medium
5.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$193,915
Total received (2018-2024)
Avg $27,702/year across 7 years
Top 3% in TX for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
717
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$36,039
2023
$27,419
2022
$17,887
2021
$15,244
2020
$11,873
2019
$49,574
2018
$35,878

Payments by company (2024)

Gilead Sciences, Inc.
$34,045
ViiV Healthcare Company
$655
Insmed, Inc.
$330
EMD Serono, Inc.
$187
Shionogi Inc
$166
Merck Sharp & Dohme LLC
$113
Paratek Pharmaceuticals, Inc.
$100
ABBVIE INC.
$92
Napo Pharmaceuticals Inc
$84
Theratechnologies Inc.
$71
Astellas Pharma US Inc
$44
AIMMUNE THERAPEUTICS, INC.
$33
Cumberland Pharmaceuticals, Inc.
$29
Eurofins Viracor, LLC
$25
La Jolla Pharmaceutical Company
$18
Ferring Pharmaceuticals Inc.
$16
Octapharma USA, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
Top 3 companies account for 97.2% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$113,048
Merck Sharp & Dohme Corporation
$52,537
Insmed, Inc.
$14,720
Merck Sharp & Dohme LLC
$4,982
ViiV Healthcare Company
$2,155
PFIZER INC.
$1,523
Theratechnologies Inc.
$918
Cumberland Pharmaceuticals, Inc.
$621
EMD Serono, Inc.
$519
Janssen Biotech, Inc.
$504
Shionogi Inc
$493
ABBVIE INC.
$358
Paratek Pharmaceuticals, Inc.
$271
Janssen Products, LP
$185
Astellas Pharma US Inc
$133
Takeda Pharmaceuticals U.S.A., Inc.
$126
Ferring Pharmaceuticals Inc.
$113
Napo Pharmaceuticals Inc
$98
AbbVie Inc.
$89
Grifols USA, LLC
$72
La Jolla Pharmaceutical Company
$52
Amgen Inc.
$49
MAYNE PHARMA INC.
$49
AIMMUNE THERAPEUTICS, INC.
$33
NESTLE HEALTHCARE NUTRITION INC.
$33
Melinta Therapeutics, LLC
$30
Octapharma USA, Inc.
$29
TETRAPHASE PHARMACEUTICALS, INC.
$26
Eurofins Viracor, LLC
$25
Genentech USA, Inc.
$23
ConvaTec Inc.
$22
GlaxoSmithKline, LLC.
$18
VYERA PHARMACEUTICALS, LLC
$16
Pharming Healthcare, Inc.
$16
AngioDynamics, Inc.
$15
Janssen Scientific Affairs, LLC
$12
Top 3 companies account for 93.0% of all-time payments
Associated products mentioned in payments ›
ANGIOVAC · APRETUDE · AVSOLA · AVYCAZ · Actemra · Arikayce · Biktarvy · CABENUVA · CRESEMBA · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DOVATO · Daraprim · EGRIFTA · Fetroja · GATTEX · Gamunex-C · HYQVIA · INNOVAMATRIX AC · ISENTRESS · JULUCA · Kimyrsa · LIVTENCITY · MK-8591A · Mytesi · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · PANZYGA · PIFELTRO · PREVYMIS · PREZCOBIX · PREZISTA · REBYOTA · RUCONEST · SEROSTIM · SHINGRIX · SYMTUZA · Serostim · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · VIBATIV · VOWST · Veklury · Vibativ · XERAVA · Xerava · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an infectious disease specialist in Fort Worth?
Compare infectious diseases in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases in nearby ZIP areas
51
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McDonald is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McDonald experienced with immune globulin infusion (gammagard)?
Based on Medicare claims data, Dr. McDonald performed 14,940 immune globulin infusion (gammagard) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McDonald receive payments from pharmaceutical companies?
Yes. Dr. McDonald received a total of $193,915 from 36 companies across 717 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McDonald's costs compare to other infectious diseases in Fort Worth?
Dr. McDonald's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McDonald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →